Latest News and Press Releases
Want to stay updated on the latest news?
-
...
-
Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022 (Article 223-16 of the General Regulations of the Autorité des...
-
Montrouge, France, le 12 mai (22h30 CET) 2022 DBV Technologies annonce les résultats de son Assemblée générale ordinaire et extraordinaire 2022 Toutes les résolutions proposées à l’Assemblée ont été...
-
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting Shareholders Approved All Proposed Resolutions DBV Technologies...
-
Montrouge, France, 5 mai (1h30 CEST) 2022 DBV Technologies réalise un placement d’ADS pour un montant de 15,3 millions de dollars sur le Nasdaq dans le cadre de son programme At-The-Market (ATM) ...
-
Montrouge, France, May 5, 2022 DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM) DBV Technologies (Euronext: DBV – ISIN:...
-
Montrouge, France, le 2 mai (22h45 CEST) 2022 DBV Technologies met en place un programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN: FR0010417345 – Nasdaq Global...
-
Montrouge, France, May 2, 2022 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Global Select Market: DBVT) (the...
-
Montrouge, France, le 2 mai 2022 DBV Technologies fait le point sur le développement de ses activités et annonce ses résultats financiers du premier trimestre 2022 La Food and Drug Administration...
-
Montrouge, France, May 2, 2022 DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results The U.S. Food and Drug Administration (FDA) has granted DBV...